Matthaei S, Hamann A, Klein H H, Benecke H, Kreymann G, Flier J S, Greten H
Department of Medicine, University-Hospital of Hamburg, Germany.
Diabetes. 1991 Jul;40(7):850-7. doi: 10.2337/diab.40.7.850.
To examine the cellular mechanism of the antihyperglycemic action of metformin, we studied its effect on various functional and molecular parameters involved in the pathogenesis of insulin resistance. Isolated rat adipocytes were incubated with or without metformin (1-100 micrograms/ml) for 2 h at 37 degrees C followed by an incubation with or without insulin (1.72 nM). Metformin treatment had no significant effect on basal 3-O-methylglucose uptake. In contrast, metformin increased insulin-stimulated glucose transport in a dose-dependent manner up to 43 +/- 7%. This effect was neither associated with a significant effect of metformin on trace insulin binding (1.74 +/- 0.20% without metformin vs. 1.89 +/- 0.30% with metformin; P greater than 0.05) nor with an effect of metformin on insulin-receptor kinase activity as measured by 32P incorporation into the 95,000-Mr beta-subunit of the insulin receptor and an exogenous substrate, histone 2B.(ABSTRACT TRUNCATED AT 250 WORDS)
为研究二甲双胍降血糖作用的细胞机制,我们研究了其对胰岛素抵抗发病机制中各种功能和分子参数的影响。将分离的大鼠脂肪细胞在37℃下分别在有或无二甲双胍(1 - 100微克/毫升)的情况下孵育2小时,随后在有或无胰岛素(1.72纳摩尔)的情况下孵育。二甲双胍处理对基础3 - O - 甲基葡萄糖摄取无显著影响。相反,二甲双胍以剂量依赖方式增加胰岛素刺激的葡萄糖转运,增幅高达43±7%。此效应既与二甲双胍对微量胰岛素结合无显著影响(无二甲双胍时为1.74±0.20%,有二甲双胍时为1.89±0.30%;P>0.05)无关,也与二甲双胍对胰岛素受体激酶活性无影响无关,胰岛素受体激酶活性通过将32P掺入胰岛素受体95,000道尔顿的β亚基和外源性底物组蛋白2B来测定。(摘要截短于250字)